MedTrace Logo

An Integrative Intervention for Loss of Control Eating Among Adolescent Girls

NCT01395355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2015-05-08

No results posted yet for this study

Summary

This study aims to develop a manualized and culturally sensitive intervention for adolescent girls targeting binge and loss of control (LOC) eating. The investigators will evaluate the feasibility and acceptability of the intervention in a controlled pilot trial. The investigators hypothesize that this intervention will serve to reduce binge and LOC eating, as well as improve psychosocial functioning as evidenced by decreased depression, anxiety, eating disorder cognitions, and impulsivity, and improved quality of life.

Conditions

  • Binge Eating/Loss of Control Eating

Interventions

BEHAVIORAL

Linking Individuals Being Emotionally Real (LIBER8)

Participants will attend a 8-12 week, 1-2 hours long intervention comprised of cognitive behavior and dialectical behavior therapy techniques.

BEHAVIORAL

Weight Management Control

Participants will attend a 8-12 week, 1-2 hours long intervention comprised of behavioral techniques.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Suzanne E Mazzeo, PhD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
22 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01395355 on ClinicalTrials.gov